<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p63" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_63{left:130px;bottom:1196px;letter-spacing:-0.15px;}
#t2_63{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_63{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_63{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_63{left:238px;bottom:1076px;letter-spacing:-0.01px;}
#t6_63{left:238px;bottom:1057px;letter-spacing:-0.01px;}
#t7_63{left:238px;bottom:1037px;letter-spacing:-0.01px;}
#t8_63{left:238px;bottom:1018px;letter-spacing:-0.01px;}
#t9_63{left:128px;bottom:954px;letter-spacing:-0.2px;}
#ta_63{left:238px;bottom:954px;letter-spacing:-0.23px;}
#tb_63{left:141px;bottom:914px;letter-spacing:-0.01px;}
#tc_63{left:248px;bottom:914px;letter-spacing:0.12px;}
#td_63{left:141px;bottom:882px;letter-spacing:0.22px;}
#te_63{left:250px;bottom:877px;letter-spacing:-0.01px;}
#tf_63{left:250px;bottom:858px;letter-spacing:-0.01px;}
#tg_63{left:143px;bottom:834px;}
#th_63{left:141px;bottom:799px;letter-spacing:-0.03px;}
#ti_63{left:248px;bottom:799px;letter-spacing:-0.03px;}
#tj_63{left:141px;bottom:752px;letter-spacing:-0.3px;}
#tk_63{left:248px;bottom:724px;letter-spacing:-0.04px;}
#tl_63{left:141px;bottom:653px;letter-spacing:-0.01px;}
#tm_63{left:248px;bottom:654px;letter-spacing:0.25px;}
#tn_63{left:143px;bottom:596px;letter-spacing:-0.29px;}
#to_63{left:250px;bottom:616px;letter-spacing:-0.01px;}
#tp_63{left:250px;bottom:597px;letter-spacing:-0.01px;}
#tq_63{left:248px;bottom:561px;letter-spacing:-0.04px;}
#tr_63{left:141px;bottom:490px;letter-spacing:-0.01px;}
#ts_63{left:248px;bottom:491px;letter-spacing:0.25px;}
#tt_63{left:143px;bottom:433px;letter-spacing:-0.29px;}
#tu_63{left:250px;bottom:453px;letter-spacing:-0.01px;}
#tv_63{left:250px;bottom:434px;letter-spacing:-0.01px;}
#tw_63{left:248px;bottom:378px;letter-spacing:-0.04px;}
#tx_63{left:141px;bottom:307px;letter-spacing:-0.01px;}
#ty_63{left:248px;bottom:308px;letter-spacing:0.25px;}
#tz_63{left:143px;bottom:250px;letter-spacing:-0.29px;}
#t10_63{left:250px;bottom:270px;letter-spacing:-0.01px;}
#t11_63{left:248px;bottom:215px;letter-spacing:-0.04px;}
#t12_63{left:238px;bottom:155px;letter-spacing:-0.01px;}
#t13_63{left:238px;bottom:136px;letter-spacing:-0.01px;}
#t14_63{left:238px;bottom:117px;letter-spacing:-0.01px;}
#t15_63{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_63{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_63{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_63{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_63{font-size:15px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_63{font-size:8px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_63{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s6_63{font-size:10px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts63" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg63Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg63" style="-webkit-user-select: none;"><object width="908" height="1286" data="63/63.svg" type="image/svg+xml" id="pdf63" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_63" class="t s0_63">7.3. Fundamental considerations of multimodal therapy approaches </span><span id="t2_63" class="t s1_63">63 </span>
<span id="t3_63" class="t s2_63">A review of the available studies confirmed these results [207]. Although only a small </span>
<span id="t4_63" class="t s2_63">proportion of the patients in the IMRT studies had laryngeal carcinoma, it can be assumed </span>
<span id="t5_63" class="t s2_63">that these results are also valid for laryngeal cancer, at least in the case of locally advanced </span>
<span id="t6_63" class="t s2_63">tumors. These data are particularly important for the treatment of carcinomas of the larynx </span>
<span id="t7_63" class="t s2_63">and hypopharynx, when the possibility of maintaining function must be weighed against a </span>
<span id="t8_63" class="t s2_63">surgical procedure as a differentiation or quality criterion. </span>
<span id="t9_63" class="t s3_63">7.3.1.1. </span><span id="ta_63" class="t s3_63">Fractionation and total dose of radiotherapy </span>
<span id="tb_63" class="t s2_63">7.23. </span><span id="tc_63" class="t s1_63">Evidence-based recommendation </span>
<span id="td_63" class="t s4_63">Recommendation level </span>
<span id="te_63" class="t s2_63">In the lymph node levels to be electively irradiated, the dose should be between 50 Gy </span>
<span id="tf_63" class="t s2_63">and 60 Gy, depending on the risk, with single doses of 1.5 to 2.0 Gy. </span>
<span id="tg_63" class="t s5_63">B </span>
<span id="th_63" class="t s6_63">Level of Evidence </span><span id="ti_63" class="t s6_63">[208-210] </span>
<span id="tj_63" class="t s5_63">1b </span>
<span id="tk_63" class="t s6_63">Strong consensus: 100% </span>
<span id="tl_63" class="t s2_63">7.24. </span><span id="tm_63" class="t s0_63">Consensus-based recommendation </span>
<span id="tn_63" class="t s5_63">EEC </span>
<span id="to_63" class="t s2_63">Therapy breaks beyond the planned weekend breaks should be avoided during </span>
<span id="tp_63" class="t s2_63">radiotherapy. </span>
<span id="tq_63" class="t s6_63">Strong consensus: 100% </span>
<span id="tr_63" class="t s2_63">7.25. </span><span id="ts_63" class="t s0_63">Consensus-based recommendation </span>
<span id="tt_63" class="t s5_63">EEC </span>
<span id="tu_63" class="t s2_63">If possible, unplanned therapy breaks should be compensated by irradiation twice </span>
<span id="tv_63" class="t s2_63">daily on 1-2 days of the week with an unchanged single dose. </span>
<span id="tw_63" class="t s6_63">Strong consensus: 100% </span>
<span id="tx_63" class="t s2_63">7.26. </span><span id="ty_63" class="t s0_63">Consensus-based recommendation </span>
<span id="tz_63" class="t s5_63">EEC </span>
<span id="t10_63" class="t s2_63">There should be an interval of at least 6 hours between two fractions. </span>
<span id="t11_63" class="t s6_63">Strong consensus: 100% </span>
<span id="t12_63" class="t s2_63">In conventional fractionated radiotherapy of head and neck tumors and thus also laryngeal </span>
<span id="t13_63" class="t s2_63">carcinomas, 5 fractions per week with 1.8 - 2.0 Gy single dose are applied. The total doses </span>
<span id="t14_63" class="t s2_63">depend on the potential tumor load in the irradiated </span>
<span id="t15_63" class="t s0_63">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
